Abstract
Objective
Left recurrent laryngeal nerve (no.106recL) lymph node dissection is a challenging procedure, and robotic-assisted minimally invasive esophagectomy (RAMIE) may have some advantages. This study aimed to determine the learning curve of no.106recL lymph node dissection.
Methods
The data of 417 patients who underwent McKeown RAMIE between June 2017 and June 2022 were retrospectively analyzed. The lymph node harvest of no.106recL was used to determine the learning curve, and the cumulative sum (CUSUM) method was employed to obtain the inflection point.
Results
A total of 404 patients (404/417, 96.9%) underwent robotic surgery. Based on the number of no.106recL lymph nodes harvested, the CUSUM learning curve was mapped and divided into three phases: phase I (1‒75 cases), phase II (76‒240 cases), and phase III (241‒404 cases). The median (IQR) number of no.106recL lymph node harvests were 1 (4), 3 (6,) and 4 (4) in each phase (p < 0.001). The lymph node dissection rate gradually increased from 62.7% in phase I to 82.9% in phase III (p = 0.001). The total and thoracic lymph node harvest gradually increased (p < 0.001), whereas operation time (p = 0.001) and blood loss gradually decreased (p < 0.001). Moreover, the incidence of total complication (p = 0.020) and recurrent laryngeal nerve injury (p = 0.001) significantly decreased, and the postoperative hospital stay gradually shortened (p < 0.001).
Conclusion
Robotic no.106recL lymph node dissection has some advantages for patients with esophageal cancer. In this study, perioperative and clinical outcomes were significantly improved over the learning curve. However, further prospective studies are required to confirm our results.
Similar content being viewed by others
References
van der Sluis PC, van der Horst S, May AM, et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: a randomized controlled trial. Ann Surg. 2019;269(4):621–30.
Suda K, Ishida Y, Kawamura Y, et al. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes. World J Surg. 2012;36(7):1608–16.
Chen J, Liu Q, Zhang X, et al. Comparisons of short-term outcomes between robot-assisted and thoraco-laparoscopic esophagectomy with extended two-field lymph node dissection for resectable thoracic esophageal squamous cell carcinoma. J Thorac Dis. 2019;11(9):3874–80.
Yang Y, Zhang X, Li B, et al. Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study. Dis Esophagus. 2020; 33(6):doz080.
Chao YK, Hsieh MJ, Liu YH, et al. Lymph node evaluation in robot-assisted versus video-assisted thoracoscopic esophagectomy for esophageal squamous cell carcinoma: a propensity-matched analysis. World J Surg. 2018;42(2):590–8.
Deng HY, Luo J, Li SX, et al. Does robot-assisted minimally invasive esophagectomy really have the advantage of lymphadenectomy over video-assisted minimally invasive esophagectomy in treating esophageal squamous cell carcinoma? A propensity score-matched analysis based on short-term outcomes. Dis Esophagus. 2019; 32(7): doy110.
Yang Y, Li B, Yi J, et al. Robot-assisted versus conventional minimally invasive esophagectomy for resectable esophageal squamous cell carcinoma: early results of a multicenter randomized controlled trial: the RAMIE trial. Ann Surg. 2022;275(4):646–53.
Tsunoda S, Obama K, Hisamori S, et al. Lower incidence of postoperative pulmonary complications following robot-assisted minimally invasive esophagectomy for esophageal cancer: propensity score-matched comparison to conventional minimally invasive esophagectomy. Ann Surg Oncol. 2021;28(2):639–47.
Leng X, He W, Yang H, et al. Prognostic impact of postoperative lymph node metastases after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of esophagus: from the results of NEOCRTEC5010, a randomized multicenter study. Ann Surg. 2019;274(6):e1022–9.
Wang Z, Mao Y, Gao S, et al. Lymph node dissection and recurrent laryngeal nerve protection in minimally invasive esophagectomy. Ann N Y Acad Sci. 2020;1481(1):20–9.
Duan X, Yue J, Chen C, et al. Lymph node dissection around left recurrent laryngeal nerve: robot-assisted vs video-assisted McKeown esophagectomy for esophageal squamous cell carcinoma. Surg Endosc. 2021;35(11):6108–16.
Park SY, Kim DJ, Kang DR, Haam SJ. Learning curve for robotic esophagectomy and dissection of bilateral recurrent laryngeal nerve nodes for esophageal cancer. Dis Esophagus. 2017;30(12):1–9.
Zhang H, Chen L, Wang Z, et al. The learning curve for robotic Mckeown esophagectomy in patients with esophageal cancer. Ann Thorac Surg. 2018;105(4):1024–30.
van der Sluis PC, Ruurda JP, van der Horst S, et al. Learning curve for robot-assisted minimally invasive thoracoscopic esophagectomy: results from 312 cases. Ann Thorac Surg. 2018;106(1):264–71.
Yang Y, Li B, Hua R, et al. Assessment of quality outcomes and learning curve for robot-assisted minimally invasive mckeown esophagectomy. Ann Surg Oncol. 2021;28(2):676–84.
Shang X, Zhao G, Liang F, et al. Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001). Ann Transl Med. 2022;10(4):229.
Shang X, Zhang W, Zhao G, et al. Pembrolizumab combined with neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy followed by surgery for locally advanced oesophageal squamous cell carcinoma: protocol for a multicentre, prospective, randomized-controlled, phase III clinical study (Keystone-002). Front Oncol. 2022;12:831345.
Cuesta MA, Weijs TJ, Bleys RL, et al. A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy. Surg Endosc. 2015;29(9):2576–82.
Tsunoda S, Shinohara H, Kanaya S, et al. Mesenteric excision of upper esophagus: a concept for rational anatomical lymphadenectomy of the recurrent laryngeal nodes in thoracoscopic esophagectomy. Surg Endosc. 2020;34:133–41.
Fujiwara H, Kanamori J, Nakajima Y, et al. An anatomical hypothesis: a “concentric-structured model” for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection. Dis Esophagus. 2019, 32(8):doy119.
Hirakawa Y, Noma K, Maeda N, et al. Microanatomy-based standardization of left upper mediastinal lymph node dissection in thoracoscopic esophagectomy in the prone position. Surg Endosc. 2021;35(1):349–57.
Shirakawa Y, Noma K, Kunitomo T, et al. Initial introduction of robot-assisted, minimally invasive esophagectomy using the microanatomy-based concept in the upper mediastinum. Surg Endosc. 2021;35(12):6568–76.
Lee HN, Kim JI, Shin SY, et al. Combined CT texture analysis and nodal axial ratio for detection of nodal metastasis in esophageal cancer. Br J Radiol. 2020;93(1111):20190827.
Xie C, Hu Y, Han L, et al. Prediction of individual lymph node metastatic status in esophageal squamous cell carcinoma using routine computed tomography imaging: comparison of size-based measurements and radiomics-based models. Ann Surg Oncol. 2022;29:8117–26.
Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg. 2015;262(2):286–94.
Rice TW, Ishwaran H, Hofstetter WL, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging. Dis Esophagus. 2016;29(8):897-905.
Prasad P, Wallace L, Navidi M, et al. Learning curves in minimally invasive esophagectomy: a systematic review and evaluation of benchmarking parameters. Surgery. 2022;171(5):1247–56.
Chao YK, Tsai CY, Illias AM, et al. A standardized procedure for upper mediastinal lymph node dissection improves the safety and efficacy of robotic McKeown oesophagectomy. Int J Med Robot. 2021;17(3):e2244.
Zhang Y, Dong D, Cao Y, et al. Robotic versus conventional minimally invasive esophagectomy for esophageal cancer: a meta-analysis. Ann Surg. 2022. https://doi.org/10.1097/SLA.0000000000005782.
Acknowledgment
This study was partially funded by the Beijing Xisike Clinical Oncology Research Foundation (Grant Numbers: Y-MSD2020-0346 and Y-MSDZD-2021-0239), Beijing-Tianjin-Hebei Basic Research Project of the Tianjin Science and Technology Bureau (Grant Number: 20JCZXJC00050), Important Specific Projects of Public Health of the Tianjin Science and Technology Bureau (Grant Number: 21ZXGWSY00020), Tianjin Health Science and Technology Talent Cultivation Project (Grant Number: KJ20135), Construction Project of Precision Treatment of Oncology Surgery in the Tianjin Medical University Cancer Hospital (Grant Number: ZLWKJZZL02), and The “14th Five-Year” Peak Discipline Support Program of the Tianjin Medical University Cancer Hospital (Grant Number: 7-2-17).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare no conflicts of interest pertaining to this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Duan, X., Yue, J., Shang, X. et al. Learning Curve of Robot-Assisted Lymph Node Dissection of the Left Recurrent Laryngeal Nerve: A Retrospective Study of 417 Patients. Ann Surg Oncol 30, 3991–4000 (2023). https://doi.org/10.1245/s10434-023-13430-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13430-6